Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion

Background. Hepatitis C virus (HCV) treatment access among human immunodeficiency virus (HIV)/HCV-coinfected people who inject drugs is poor, despite a high burden of disease in this population. Understanding barriers and facilitators to HCV treatment uptake is critical to the implementation of new...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Carissa E., Wu, Feng, He, Xi, Zhou, Kali, Cheng, Yu, Cai, Weiping, Geng, Elvin, Volberding, Paul, Tucker, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943171/
https://www.ncbi.nlm.nih.gov/pubmed/27419150
http://dx.doi.org/10.1093/ofid/ofw065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943171/
https://www.ncbi.nlm.nih.gov/pubmed/27419150
http://dx.doi.org/10.1093/ofid/ofw065

Ejemplares similares